⌘K

Login Start Free

Home/Filings/4/0000899243-19-024732

4//SEC Filing

Thierer Mark 4

Accession 0000899243-19-024732

CIK 0001346302other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:12 PM ET

Size

5.3 KB

Accession

0000899243-19-024732

Insider Transaction Report

Form 4

Period: 2019-09-30

XERIS PHARMACEUTICALS INCXERS

Director

Transactions

Award
Stock Option (right to buy)
2019-09-30+19,650→ 19,650 total
Exercise: $9.83Exp: 2029-09-30→ Common Stock (19,650 underlying)

Footnotes (1)

[F1]The options will vest monthly over three years, subject to continued service as a director through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

XERIS PHARMACEUTICALS INC

CIK 0001346302

Entity typeother

Related Parties

1

filerCIK 0001334925

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 5:12 PM ET
Size: 5.3 KB

View on SEC.gov